Showing 1 - 8 results of 8 for search 'Slade D', query time: 0.04s
Refine Results
-
1
Selective inhibition of divergent seryl-tRNA synthetases by serine analogues. by Ahel, D, Slade, D, Mocibob, M, Söll, D, Weygand-Durasevic, I
Published 2005Journal article -
2
The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase. by Slade, D, Dunstan, MS, Barkauskaite, E, Weston, R, Lafite, P, Dixon, N, Ahel, M, Leys, D, Ahel, I
Published 2011Journal article -
3
Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Co... by Kalhan R, Slade D, Ray R, Moretz C, Germain G, Laliberté F, Shen Q, Duh MS, MacKnight SD, Hahn B
Published 2021-04-01
Article -
4
Identification of macrodomain proteins as novel O-acetyl-ADP-ribose deacetylases. by Chen, D, Vollmar, M, Rossi, M, Phillips, C, Kraehenbuehl, R, Slade, D, Mehrotra, P, von Delft, F, Crosthwaite, S, Gileadi, O, Denu, J, Ahel, I
Published 2011Journal article -
5
Identification of macrodomain proteins as novel O-acetyl-ADP-ribose deacetylases. by Chen, D, Vollmar, M, Rossi, M, Phillips, C, Kraehenbuehl, R, Slade, D, Mehrotra, P, von Delft, F, Crosthwaite, S, Gileadi, O, Denu, J, Ahel, I
Published 2011Journal article -
6
CATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults by Veenith, T, Fisher, BA, Slade, D, Rowe, A, Sharpe, R, Thickett, DR, Whitehouse, T, Rowland, M, Scriven, J, Parekh, D, Bowden, SJ, Savage, JS, Richards, D, Bion, J, Kearns, P, Gates, S
Published 2021Journal article -
7
Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT. by Innes, A, Beattie, R, Sergeant, R, Damaj, D, Foroni, L, Marin, D, Kanfer, E, Mielke, S, Milojkovic, D, MacDonald, D, Pavlu, J, Rahemtulla, A, Roberts, I, Slade, D, Bray, E, Goldman, J, Apperley, J, Szydlo, R, Dazzi, F, Rezvani, K
Published 2013Journal article -
8
Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, ph... by Fisher, BA, Veenith, T, Slade, D, Gaskell, C, Rowland, M, Whitehouse, T, Scriven, J, Parekh, D, Balasubramaniam, MS, Cooke, G, Morley, N, Gabriel, Z, Wise, MP, Porter, J, McShane, H, Ho, L-P, Newsome, PN, Rowe, A, Sharpe, R, Thickett, DR, Bion, J, Gates, S, Richards, D, Kearns, P, Williams, B, Turner, R, Libri, V, Mussai, F, Middleton, G, Bowden, S, Bangash, M, Gao-Smith, F, Patel, J, Sapey, E, Thomas, M, Coles, M, Watkinson, P, Rahman, N, Angus, B, Mentzer, AJ, Novak, A, Feldman, M, Richter, A, Faustini, S, Bathurst, C, Van de Wiel, J, Mee, S, James, K, Rahman, B
Published 2021Journal article